Welcome to Our Parkinson's Place

I copy news articles pertaining to research, news and information for Parkinson's disease, Dementia, the Brain, Depression and Parkinson's with Dystonia. I also post about Fundraising for Parkinson's disease and events. I try to be up-to-date as possible. I have Parkinson's
diseases as well and thought it would be nice to have a place where
updated news is in one place. That is why I began this blog.
I am not responsible for it's contents, I am just a copier of information searched on the computer. Please understand the copies are just that, copies and at times, I am unable to enlarge the wording or keep it uniformed as I wish. This is for you to read and to always keep an open mind.
Please discuss this with your doctor, should you have any questions, or concerns. Never do anything without talking to your doctor. I do not make any money from this website. I volunteer my time to help all of us to be informed. Please No advertisers, and No Information about Herbal treatments. Please no advertisements.
This is a free site for all.
Thank you.

Friday, April 7, 2017

Parkinson's disease risk found higher for statin users

April 6, 2017

  Statin users were more likely to develop Parkinson's disease, especially in the first few years of use and when taking the drugs with nonstatin lipid-lowering drugs.

Why this matters
  A large share of the population takes statins, and their association with neurologic conditions is unclear in part because of publication bias.

Key results 
  Statin users had an elevated risk for Parkinson's disease relative to nonusers.
  In stratified analysis, risk was elevated for users of lipophilic statins (OR, 1.58; P<.0001), but not users of hydrophilic statins.
  Greatest elevation of risk was seen for individuals taking both statins and nonstatin lipid-lowering medications (OR, 1.95; P<.0001).
  Odds were highest in the first year of use (OR, 1.82), fell between 1 and 2.5 y (OR, 1.75), and fell even more thereafter (OR, 1.37) (Ptrend<.0001).

Study design
  A retrospective case-control study using claims data of 2322 patients with incident Parkinson's disease and 2322 matched control individuals without the disease.
  The main outcome was Parkinson's disease.
  Funding: Tobacco Commonwealth Universal Research Enhancement Program (CURE) General Clinical Research Center.

  Only commercially insured individuals were included.
  Patients with Parkinson's disease were identified with diagnosis codes.
  Lipid levels were not available.

Liu G, Sterling NW, Kong L, Lewis MM, Mailman RB, Chen H, Leslie D, Huang X. Statins may facilitate Parkinson's disease: Insight gained from a large, national claims database. Mov Disord. 2017 Apr 3 [Epub ahead of print]. doi: 10.1002/mds.27006. PMID: 28370314

No comments:

Post a Comment